Understanding artificial neural networks and exploring their potential applications for the practicing urologist

Urology

Volumn 52, Issue 2, 1998, Pages 161-172

  Wei, John T ^a   Zhang, Zhen ^b   Barnhill, Stephen D ^b   Madyastha, K Rama ^b   Zhang, Hong ^b   Oesterling, Joseph E ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; PROSTATE SPECIFIC ANTIGEN;

ARTIFICIAL NEURAL NETWORK; ASSAY; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; INFORMATION PROCESSING; LITHOTRIPSY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; STATISTICAL ANALYSIS; TESTIS BIOPSY; UROLOGY;

CLINICAL MEDICINE; FORECASTING; HUMANS; LEARNING; MODELS, STATISTICAL; NEURAL NETWORKS (COMPUTER); UROLOGY;

EID: 0032146619     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00181-2     Document Type: Review

References (83)

1. Cupp M.R., Oesterling J.E. Prostate-specific antigen, digital rectal examination, and transrectal ultrasonography their roles in diagnosing early prostate cancer . Mayo Clin Proc. 68:1993;297-306.
2. Wang M.C., Valenzuela L.A., Murphy G.P., et al. Purification of a human prostate specific antigen. Invest Urol. 17:1979;159-163.
3. Watt K.W., Lee P.J., M'Timkulu T., et al. Human prostate-specific antigen structural and functional similarity with serine proteases . Proc Natl Acad Sci USA. 83:1986;3166-3170.
4. Lundwall A., Lilja H. Molecular cloning of human prostate specific antigen cDNA. FEBS Lett. 214:1987;317-322.
5. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest. 76:1985;1899-1903.
6. Partin A.W., Oesterling J.E. The clinical usefulness of prostate specific antigen update 1994 . J Urol. 152:(5 Pt 1):1994;1358-1368.
7. Benson M.C., Whang I.S., Pantuck A., et al. Prostate specific antigen density a means of distinguishing benign prostatic hypertrophy and prostate cancer . J Urol. 147:(Pt 2):1992;815-816.
8. Carter H.B., Pearson J.D. PSA velocity for the diagnosis of early prostate cancer A new concept . Urol Clin North Am. 20:1993;665-670.
9. Oesterling J.E., Jacobsen S.J., Chute C.G., et al. Serum prostate-specific antigen in a community-based population of healthy men Establishment of age-specific reference ranges . JAMA. 270:1993;860-864.
10. Lilja H. Significance of different molecular forms of serum PSA The free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin . Urol Clin North Am. 20:1993;681-686.
11. Rosenblatt F. The perceptron a probabilistic model for information storage and organization in the brain . Psychol Rev. 65:1958;386-408.
12. Hinton G.E. How neural networks learn from experience. Sci Am. 267:1992;144-151.
13. Agyei-Mensah S.O., Lin F.C. Application of neural networks in medical diagnosis the case of sexually-transmitted diseases . Austr Phys Eng Sci Med. 15:1992;186-192.
14. Patil S., Henry J.W., Rubenfire M., et al. Neural network in the clinical diagnosis of acute pulmonary embolism. Chest. 104:1993;1685-1689.
15. Somoza E., Somoza J.R. A neural-network approach to predicting admission decisions in a psychiatric emergency room. Med Decis Making. 13:1993;273-280.
16. Mann N.H. III, Brown M.D. Artificial intelligence in the diagnosis of low back pain. Orthop Clin North Am. 22:1991;303-314.
17. Kippenhan J.S., Barker W.W., Pascal S., et al. Evaluation of a neural-network classifier for PET scans of normal and Alzheimer's disease subjects. J Nucl Med. 33:1992;1459-1467.
18. Astion M.L., Wilding P. Application of neural networks to the interpretation of laboratory data in cancer diagnosis. Clin Chem. 38:1992;34-38.
19. Reibnegger G., Weiss G., Werner-Felmayer G., et al. Neural networks as a tool for utilizing laboratory information comparison with linear discriminant analysis and with classification and regression trees . Proc Natl Acad Sci USA. 88:1991;11426-11430.
20. Kennedy R.L., Harrison R.F., Burton A.M., et al. An artificial neural network system for diagnosis of acute myocardial infarction (AMI) in the accident and emergency department evaluation and comparison with serum myoglobin measurements . Comput Methods Programs Biomed. 52:1997;93-103.
21. Astion M.L., Wener M.H., Thomas R.G., et al. Application of neural networks to the classification of giant cell arteritis. Arthritis Rheum. 37:1994;760-770.
22. Reinus W.R., Wilson A.J., Kalman B., et al. Diagnosis of focal bone lesions using neural networks. Invest Radiol. 29:1994;606-611.
23. Wilding P., Morgan M.A., Grygotis A.E., et al. Application of backpropagation neural networks to diagnosis of breast and ovarian cancer. Cancer Lett. 77:1994;145-153.
24. Wu Y., Giger M.L., Doi K., et al. Artificial neural networks in mammography application to decision making in the diagnosis of breast cancer . Radiology. 187:1993;81-87.
25. Kalman B.L., Reinus W.R., Kwasny S.C., et al. Prescreening entire mammograms for masses with artificial neural networks preliminary results . Acad Radiol. 4:1997;405-414.
26. Lin JS, Ligomenides PA, Freedman MT, et al: Application of artificial neural networks for reduction of false-positive detections in digital chest radiographs. Proc Annu Symp Appl Med Care 1993, pp 434-438.
27. Lo S.C., Freedman M.T., Lin J.S., et al. Automatic lung nodule detection using profile matching and back-propagation neural network techniques. J Digit Imaging. 6:1993;48-54.
28. Chan H.P., Lo S.C., Sahiner B., et al. Computer-aided detection of mammographic microcalcifications pattern recognition with an artificial neural network . Med Phys. 22:1995;1555-1567.
29. Datz F.L., Rosenberg C., Gabor F.V., et al. The use of computer-assisted diagnosis in cardiac perfusion nuclear medicine studies a review . J Digit Imaging. 6:1993;67-80.
30. Chan K.H., Johnson K.A., Becker J.A., et al. A neural network classifier for cerebral perfusion imaging. J Nucl Med. 35:1994;771-774.
31. Pesonen E., Eskelinen M., Juhola M. Comparison of different neural network algorithms in the diagnosis of acute appendicitis. Int J Biomed Comput. 40:1996;227-233.
32. Baxt W.G. Use of an artificial neural network for data analysis in clinical decision-making the diagnosis of acute coronary occlusion . Neural Comput. 2:1990;480-489.
33. Baxt W.G. Use of an artificial neural network for the diagnosis of myocardial infarction. Ann Intern Med. 115:1991;843-848.
34. Baxt W.G., Skora J. Prospective validation of artificial neural network trained to identify acute myocardial infarction. Lancet. 347:1996;12-15.
35. Penny W., Frost D. Neural networks in clinical medicine. Med Decis Making. 16:1996;386-398.
36. Snoey E.R., Housset B., Guyon P., et al. Analysis of emergency department interpretation of electrocardiograms. J Accid Emerg Med. 11:1994;149-153.
37. Edenbrandt L., Devine B., Macfarlane P.W. Classification of electrocardiographic ST-T segments - human expert vs. artificial neural network. Eur Heart J. 14:1993;464-468.
38. Edenbrandt L., Heden B., Pahlm O. Neural networks for analysis of ECG complexes. J Electrocardiol. 26:(suppl):1993;74.
39. Bortolan G., Willems J.L. Diagnostic ECG classification based on neural networks. J Electrocardiol. 26:(suppl):1993;75-79.
40. Hu Y.H., Tompkins W.J., Urrusti J.L., et al. Applications of artificial neural networks for ECG signal detection and classification. J Electrocardiol. 26:(suppl):1993;66-73.
41. Heden B., Edenbrandt L., Haisty W.K. Jr. Artificial neural networks for the electrocardiographic diagnosis of healed myocardial infarction. Am J Cardiol. 74:1994;5-8.
42. Heden B., Ohlin H., Rittner R., et al. Acute myocardial infarction detected in the 12-lead ECG by artificial neural networks. Circulation. 96:1997;1798-1802.
43. Bosch M.M., Rietveld-Scheffers P.E., Boon M.E. Characteristics of false-negative smears tested in the normal screening situation. Acta Cytol. 36:1992;711-716.
44. Mango L.J. Reducing false negatives in clinical practice the role of neural network technology . Am J Obstet Gynecol. 175:(4 Pt 2):1996;1114-1119.
45. Molnar B., Szentirmay Z., Bodo M., et al. Application of multivariate, fuzzy set and neural network analysis in quantitative cytological examinations. Anal Cell Pathol. 5:1993;161-175.
46. Downs J., Cross S.S., Harrison R.F. Diagnosis of breast fine-needle aspirates using a revised adaptive resonance theory mapping neural network (abstract). J Pathol. 176:(suppl):1995;9A.
47. Mango L.J. Clinical validation of interactive cytologic screening Automating the search, not the interpretation . Acta Cytol. 41:1997;93-97.
48. Coste J., Paolaggi J.B., Spira A. Reliability of interpretation of plain lumbar spine radiographs in benign, mechanical low-back pain. Spine. 16:1991;426-428.
49. Doig GS, Inman KJ, Sibbald WJ, et al: Modeling mortality in the intensive care unit: comparing the performance of a back-propagation, associative-learning neural network with multivariate logistic regression. Proc Annu Symp Comput Appl Med Care 1993, pp 361-365.
50. Burke H.B., Goodman P.H., Rosen D.B., et al. Artificial neural networks improve the accuracy of cancer survival prediction. Cancer. 79:1997;857-862.
51. Tu J.V., Guerriere M.R. Use of a neural network as a predictive instrument for length of stay in the intensive care unit following cardiac surgery. Comput Biomed Res. 26:1993;220-229.
52. Davis G.E., Lowell W.E., Davis G.L. A neural network that predicts psychiatric length of stay. MD Comput. 10:1993;87-92.
53. Davis G.E., Lowell W.E., Davis G.L. Measuring quality of care in a psychiatric hospital using artificial neural networks. Am J Med Qual. 12:1997;33-43.
54. Modai I., Stoler M., Inbar-Saban N., et al. Clinical decisions for psychiatric inpatients and their evaluation by a trained neural network. Methods Inf Med. 32:1993;396-399.
55. Ebell M.H. Artificial neural networks for predicting failure to survive following in-hospital cardiopulmonary resuscitation. J Fam Pract. 36:1993;297-303.
56. Doyle H.R., Dvorchik I., Mitchell S., et al. Predicting outcomes after liver transplantation A connectionist approach . Ann Surg. 219:1994;408-415.
57. Maclin P.S., Dempsey J., Brooks J., et al. Using neural networks to diagnose cancer. J Med Syst. 15:1991;11-19.
58. Prater J.S., Richard W.D. Segmenting ultrasound images of the prostate using neural networks. Ultrason Imaging. 142:1992;159-185.
59. Loch T., Leuschner I., Bruske T. Neural network analysis of subvisual transrectal ultrasound data improved prostate cancer detection . J Urol. 157:1997;364.
60. Snow P.B., Smith D.S., Catalona W.J. Artificial neural networks in the diagnosis and prognosis of prostate cancer a pilot study . J Urol. 152:1994;1923-1926.
61. Douglas T., Connelly R., McLeod D., et al. Neural network analysis of pre-operative and post-operative variables to predict pathologic stage and recurrence. J Urol. 155:1996;487A.
62. Tisman G, Strum S, Scholz M, et al: Pre-therapy prediction of the duration of post-therapy non-detectable PSA for prostate cancer patients considering intermittent combined hormonal blockade by use of computerized neural net modeling. Proceedings of the American Society of Clinical Oncology Meeting, May 1997, abstract 1236.
63. Snow P., Crawford D., DeAntoni E., et al. Prostate cancer diagnosis from artificial neural networks using the prostate cancer awareness week database. J Urol. 157:1997;365.
64. Schweiger CR, Maenner GA, Soeregi G, et al: Neural network evaluation of multiple tumor markers for diagnosis of urinary bladder cancer using three different sets of patients (abstract). Third International Conference of the Mediterranean Society of Tumor, Vienna, Austria, 1994.
65. Stamey T.A., Barnhill S.D., Zhang Z., et al. Effectiveness of ProstAsure™ in detecting prostate cancer (PCa) and benign prostatic hyperplasia (BPH) in men age 50 and older. J Urol. 155:1996;436A.
66. Barnhill S., Stamey T., Zhang Z., et al. The ability of the ProstAsure™ Index to identify prostate cancer patients with low cancer volumes and a high potential for cure. J Urol. 157:1997;63-67.
67. Babaian R, Fritsche H, and Goldman M: A comparison of ProstAsure™ Index and free/total PSA ratio in the diagnosis of prostate cancer (abstract). Association of Clinical Scientists, Salt Lake City, Utah, May 1997.
68. Stamey T., Barnhill S., Zhang Z., et al. A neural network with high sensitivity and specificity for diagnosing prostate cancer in men with a PSA <4 0 ng/ml . J Urol. 157:1997;364.
69. Stamey T.A., McNeal J.E., Freiha F.S., et al. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol. 139:1988;1235-1241.
70. Oesterling J., Wojno K., Beduschi M. The ProstAsure™ Index is useful in the diagnosis of early prostate cancer but does not predict pathologic stage in men with a PSA level less than 4 0 ng/ml . J Urol. 157:1997;462.
71. Bjork T., Piironen T., Pettersson K., et al. Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer. Urology. 48:1996;882-888.
72. Sokoll L, Bruzek D, Cox J, et al: Comparison of ProstAsure™ Indexes calculated with six total PSA assays and three PAP assays (abstract). American Association for Clinical Chemistry, Atlanta, Georgia, July 1997.
73. Moul J.W., Snow P.B., Fernandez E.B., et al. Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage I nonseminomatous testicular cancer. J Urol. 153:1995;1674-1677.
74. Stotzka R., Manner R., Bartels P.H., et al. A hybrid neural and statistical classifier system for histopathologic grading of prostatic lesions. Analytic Quant Cytol Histol. 17:1995;204-218.
75. Volmer M., Wolthers B.G., Metting H.J., et al. Artificial neural network predictions of urinary calculus compositions analyzed with infrared spectroscopy. Clin Chem. 40:1994;1692-1697.
76. Hurst R.E., Bonner R.B., Ashenayi K., et al. Neural net-based identification of cells expressing the p300 tumor-related antigen using fluorescence image analysis. Cytometry. 27:1997;36-42.
77. Neiderberger C. Computational tools for the modern andrologist. J Androl. 17:1996;462-466.
78. Neiderberger CS, Michaels DK, Cho L, et al: A neural computational model of stone recurrence after ESWL. Proceedings of the International Conference on Engineering Applications of Neural Networks, London, June 1996, pp 423-426.
79. Litwin M.S., Hays R.D., Fink A., et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 273:1995;129-135.
80. Fowler F.J. Jr, Barry M.J., Lu-Yao G., et al. Effect of radical prostatectomy for prostate cancer on patient quality of life results from a Medicare survey . Urology. 45:1995;1007-1013.
81. Barry M.J. Medical outcomes research and benign prostatic hyperplasia. Prostate Suppl. 3:1990;61-74.
82. Krongrad A., Granville L.J., Burke M.A., et al. Predictors of general quality of life in patients with benign prostate hyperplasia or prostate cancer. J Urol. 157:1997;534-538.
83. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer A multi-institutional update . JAMA. 277:1997;1445-1451.